
Investors should exercise extreme caution with MedV and the GLP-1 telehealth sector due to thin 15% margins, aggressive marketing tactics, and looming FDA regulatory scrutiny. In the AI space, monitor OpenAI for a potential IPO as early as Q4 2026, but be aware of their massive projected $121 billion compute spend through 2028. Anthropic’s acquisition of Coefficient Bio signals a high-conviction shift toward AI drug discovery, making biotech a primary value unlock for large language models. Within the defense sector, look for opportunities in "low-cost attritable systems" like the Lucas (FLM 136) drone, as the Pentagon shifts procurement toward cheaper, mass-produced autonomous weapons. Finally, the B2B stablecoin market is a high-growth area for 2025, with infrastructure providers like Better Money and Stripe benefiting from new regulatory clarity for instant corporate payouts.

By John Coogan & Jordi Hays
Technology's daily show (formerly the Technology Brothers Podcast). Streaming live on X and YouTube from 11 - 2 PM PST Monday - Friday. Available on X, Apple, Spotify, and YouTube.